Hospira Recalls Lidocaine HCl for Injection
Hospira announced a voluntary recall of 1% Lidocaine HCl for Injection after a confirmed report of particulate in a single unit. The particulate has been identified as human hair, embedded in and attached to a pinched area of the stopper.
If the particulate breaks and its pieces pass through the intravenous (IV) catheter, the material may lead to local inflammation, phlebitis, and/or low-level allergic response or microembolic effects.
The affected product has Lot #40-316-DK, NDC 0409-4279-02, and an expiration date of April 1, 2016. The recalled product is supplied as a 10mg/mL strength, in 30mL single-dose preservative-free units, and was distributed from May to June 2014.
Anyone with the affected product should discontinue use and distribution and quarantine the product. Hospira is notifying its direct customers via a letter and will arrange for return of all affected products.
For more information call (877) 546-5069 or visit Hospira.com.